安杰思收盘上涨4.03%，滚动市盈率23.31倍，总市值68.74亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Anjiasi, a company in the medical device industry, noting its low PE ratio compared to industry averages [1][2] - Anjiasi's closing stock price on August 12 was 84.89 yuan, with a 4.03% increase, resulting in a rolling PE ratio of 23.31, the lowest in 311 days, and a total market capitalization of 6.874 billion yuan [1] - The medical device industry has an average PE ratio of 57.51 and a median of 41.25, positioning Anjiasi at 48th in the industry ranking [1][2] Group 2 - As of the 2025 semi-annual report, 10 institutions hold shares in Anjiasi, including 5 other entities, 4 funds, and 1 brokerage, with a total holding of 17.6384 million shares valued at 1.143 billion yuan [1] - Anjiasi specializes in the research, production, and sales of minimally invasive diagnostic and therapeutic instruments, with key products including GI, EMR/ESD, and ERCP diagnostic series [1] - The latest performance report shows Anjiasi achieved a revenue of 302 million yuan, a year-on-year increase of 14.56%, and a net profit of 126 million yuan, maintaining a gross profit margin of 70.21% [1]